| 2024-06-04 | Sale | Olema Pharmaceuticals, Inc. OLMA | director | 1.18M 2.2298% | $14.85 | $17.45M | -11.23% | |
| 2023-12-08 | Akero Therapeutics, Inc. AKRO | director | 100,000 0.179% | $19.83 | $1.98M | +10.91% | ||
| 2023-12-05 | Olema Pharmaceuticals, Inc. OLMA | director | 131,870 0.2639% | $14.19 | $1.87M | -10.35% | ||
| 2023-12-01 | Akero Therapeutics, Inc. AKRO | director | 50,000 0.0866% | $16.99 | $849,730 | +25.51% | ||
| 2023-11-30 | Akero Therapeutics, Inc. AKRO | director | 50,000 0.0904% | $16.90 | $844,835 | +31.6% | ||
| 2023-09-19 | Akero Therapeutics, Inc. AKRO | director | 400,000 0.5235% | $26.00 | $10.4M | -57.65% | ||
| 2023-09-12 | Olema Pharmaceuticals, Inc. OLMA | director | 508,130 1.0101% | $9.84 | $5M | +1.13% | ||
| 2023-08-08 | Akero Therapeutics, Inc. AKRO | director | 25,000 0.0442% | $42.06 | $1.05M | -48.43% | ||
| 2023-08-01 | Akero Therapeutics, Inc. AKRO | director | 25,000 0.0453% | $43.26 | $1.08M | -49.52% | ||
| 2023-07-28 | Akero Therapeutics, Inc. AKRO | director | 30,000 0.0645% | $42.69 | $1.28M | -47.5% | ||
| 2023-05-19 | Akero Therapeutics, Inc. AKRO | director | 120,000 0.2354% | $42.00 | $5.04M | -47.28% | ||
| 2022-09-19 | Akero Therapeutics, Inc. AKRO | director | 400,000 0.9981% | $26.00 | $10.4M | +66.09% | ||
| 2020-12-14 | ALX Oncology Holdings Inc. ALXO | director | 40,000 0.1009% | $76.00 | $3.04M | -20.73% | ||
| 2020-11-23 | Olema Pharmaceuticals, Inc. OLMA | director | 2.32M 4.1436% | $19.00 | $44.08M | -44.3% | ||
| 2020-07-21 | ALX Oncology Holdings Inc. ALXO | director | 1.95M 4.0591% | $19.00 | $37.05M | +90.48% |